TY - JOUR
T1 - Complications of HIV infection
T2 - A systems-based approach
AU - Chu, Carolyn
AU - Selwyn, Peter A.
PY - 2011/2/15
Y1 - 2011/2/15
N2 - Patients with human immunodefciency virus (HIV) infection often develop multiple complications and comorbidities. Opportunistic infections should always be considered in the evaluation of symptomatic patients with advanced HIV/AIDS, although the overall incidence of these infections has decreased. Primary care of HIV infection includes the early detection of some complications through screening at-risk and symptomatic patients with routine laboratory monitoring (e.g., comprehensive metabolic and lipid panels) and validated tools (e.g., the HIV Dementia Scale). Treatment of many chronic complications is similar for patients with HIV infection and those without infection; however, combination antiretroviral therapy has shown beneft for some conditions, such as HIV-associated nephropathy. For other complications, such as cardiovascular disease and lipoatrophy, management may include switching antiretroviral regimens to reduce exposure to HIV medications known to cause toxicity.
AB - Patients with human immunodefciency virus (HIV) infection often develop multiple complications and comorbidities. Opportunistic infections should always be considered in the evaluation of symptomatic patients with advanced HIV/AIDS, although the overall incidence of these infections has decreased. Primary care of HIV infection includes the early detection of some complications through screening at-risk and symptomatic patients with routine laboratory monitoring (e.g., comprehensive metabolic and lipid panels) and validated tools (e.g., the HIV Dementia Scale). Treatment of many chronic complications is similar for patients with HIV infection and those without infection; however, combination antiretroviral therapy has shown beneft for some conditions, such as HIV-associated nephropathy. For other complications, such as cardiovascular disease and lipoatrophy, management may include switching antiretroviral regimens to reduce exposure to HIV medications known to cause toxicity.
UR - http://www.scopus.com/inward/record.url?scp=79956355950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79956355950&partnerID=8YFLogxK
M3 - Article
C2 - 21322514
AN - SCOPUS:79956355950
SN - 0002-838X
VL - 83
SP - 395
EP - 406
JO - American family physician
JF - American family physician
IS - 4
ER -